Bayer’s challenger to Lucentis shows promise
November 22, 2010Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD
Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …
J&J and Takeda issue recall for cancer drug Velcade
November 22, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, Takeda Pharmaceuticals, Velcade, bortezomib, pharma manufacturing, product recalls
Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …
Daiichi-Sankyo cleared of rep misconduct
November 22, 2010Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Daiichi Sankyo, Daiichi-Sankyo, Olmetec, PMCPA, olmesartan, pharma sales representative
Daiichi-Sankyo has been cleared of any wrongdoing in relation to the ABPI Code after one of its representatives was accused …
Pfizer’s axitinib impresses in head-to-head trial with Nexavar
November 22, 2010Research and Development, Sales and Marketing Kidney cancer, Nexavar, Pfizer, axitinib, mRCC, metastatic renal cell carcinoma
Pfizer’s axitinib has impressed in phase III trials assessing its efficacy as a second line treatment for renal cell carcinoma. …
Digital Pharma: E-Health and the European agenda
November 19, 2010Medical Communications Digital Agenda, Digital Pharma blog, EC, European Commission, Neelie Kroes, digital patients, e-health, electronic patient records
The European Commission wants all European patients to be given secure online access to their medical records by 2015 and …
Pharma sector growth to improve in 2011
November 19, 2010Sales and Marketing 2011, IMS, IMS Health, forecast, growth, pharma
2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …
Bayer set for 4,500 job cuts
November 19, 2010Research and Development, Sales and Marketing Bayer, Cost cutting, emerging markets
Bayer has announced large scale job losses aimed at saving 800 million euro savings in the coming years.The cuts are …
Denosumab approved for bone cancer use
November 19, 2010Sales and Marketing Amgen, Cancer, Prolia, Xgeva, denosumab
Amgen’s denosumab has been approved in the US to prevent serious bone problems in patients with solid tumour cancers. Denosumab …
Natalie Lewis and Claire Nicholson join the Red Consultancy
November 19, 2010Medical Communications Claire Nicholson, Natalie Lewis, appointment, medical communications, red consultancy, red health
The Red Consultancy has expanded its specialist health team, Red Health, with two new hires. Account director Natalie Lewis (pictured …
CME Spotlight: Medical communications evolves
November 19, 2010CME, CME Spotlight, Continuing medical education, Eugene Pozniak, medical education
I recently attended the first meeting of the MedComms Forum in Oxford. The venue of the Natural History Museum was …
New Men’s Health journal launched
November 19, 2010Medical Communications Trends in Urology and Men's Health, medical education, men's health
A new controlled circulation journal Trends in Urology and Men’s Health has been launched to help promote doctors’ awareness of …
BTG to buy Biocompatibles
November 19, 2010Research and Development BTG, Biocompatibles
BTG is to pay £156 million to acquire Biocompatibles, the drug-device specialists.Established in 1984 and floated in 1995, Biocompatibles specialises …
Synovate Healthcare appoints Dr Nicole Oehlrich
November 18, 2010Medical Communications, Sales and Marketing Dr Nicole Oehlrich, appointment, medical communications, oncology market research, sales and marketing, synovate
Global market research agency Synovate has appointed Dr Nicole Oehlrich to the role of oncology business consultant for its specialist …
Novartis outlines business strategy
November 18, 2010Research and Development, Sales and Marketing Novartis, business development, pharma strategy
Novartis has outlined its long-term strategy for managing a number of key patent expiries. The Swiss-based pharma firm plans to …
European pharma expects regulatory compliance challenges
November 18, 2010Sales and Marketing CRM, Cegedim Dendrite, Transparency Directive, regulatory compliance, transparency
European pharma companies will face major challenges over the next three years implementing new regulatory legislation and compliance requirements, according …
What would Mad Men make of the digital era?
November 18, 2010Medical Communications Creative Lynx, advertising, digital marketing
Sharp-suited creative director Don Draper from AMC’s television series ‘Mad Men’, in conversation with Creative Lynx’s David Hunt … DAVID: …
Genzyme courting ‘white knight’ bid from Takeda
November 18, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers
Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …
CP Pharma gets FDA warning for Wrexham facility
November 18, 2010Manufacturing and Production CP Pharmaceuticals, FDA, FDA warning letter, Wockhardt, manufacturing compliance, pharma manufacturing
UK drugmaker CP Pharmaceuticals is the latest to receive a warning letter from the FDA for failing to meet standards …
New ABPI Code published
November 17, 2010Medical Communications, Sales and Marketing 2011 ABPI Code, ABPI, ABPI Code of Practice, PMCPA, pharma marketing, pharma sales
The ABPI has published the 2011 version of its Code of Practice for UK pharmaceutical companies, with copies now available …
Government directs councils to supply personal health budgets
November 17, 2010Sales and Marketing big society, government, healthcare, reforms
The government announced this week that it expects local councils to provide personal health budgets to a million eligible people …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
